Seen in the press: Nemera’s article featured in February ‘European Pharmaceutical Manufacturer’


European Pharmaceutical Manufacturer magazine features Nemera’s article ‘Taking the Advanced approach’ about patient adherence for nasal spray.

The recently published European Pharmaceutical Manufacturer magazine includes the article from Nemera ‘Taking the Advanced approach’, presenting how a nasal spray improve patients’ adherence.

In this article, Pascale Farjas, Global Category Manager at Nemera, examines the design features that help improve adherence for patients using nasal spray devices.

In today’s healthcare world, there is an ever-increasing emphasis on patient-centricity. The patient is now a priority because he is the one who will experience the device.

The patient adherence is an aspect that needs all our attention. Patient non-adherence with their drug could result in non-effective therapy or even dangerous consequences for potent drugs.
To be taking in consideration, user-studies are necessary to know what the patient is thinking about the product and to try it.

Realizing the challenges nasal spray users experience when using their devices, Nemera developed a platform designed to improve the level of patient adherence.

The full article:

About Nemera

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.

Nemera’s services and products cover several key delivery routes: Ophthalmic, Nasal, Buccal, Auricular, Inhalation, Dermal/Transdermal and Parenteral.

Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and contract manufacturing.